- CTIC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $5.7 million.
- CTIC has traded 12.0 million shares today.
- CTIC is trading at 136.03 times the normal volume for the stock at this time of day.
- CTIC is trading at a new high 23.20% above yesterday's close.
'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success. EXCLUSIVE OFFER: Get the inside scoop on opportunities in CTIC with the Ticky from Trade-Ideas. See the FREE profile for CTIC NOW at Trade-Ideas More details on CTIC: CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell has a market cap of $440.5 million and is part of the health care sector and drugs industry. The stock has a beta of 1.06 and a short float of 11.2% with 9.98 days to cover. Shares are up 53.9% year-to-date as of the close of trading on Tuesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.